BTLA Antikörper (AA 190-290)
Kurzübersicht für BTLA Antikörper (AA 190-290) (ABIN2590779)
Target
Alle BTLA Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- AA 190-290
-
Spezifität
- Human BTLA / CD272
-
Aufreinigung
- Affinity purified
-
Immunogen
-
Partial recombinant protein (aa190-290) from human BTLA (NP_861445) with GST tag. MW of the GST tag alone is 26 KDa.
Type of Immunogen: Recombinant protein -
Isotyp
- IgG2a kappa
-
-
-
-
Applikationshinweise
- Approved: ELISA, IF (10 μg/mL), WB
-
Kommentare
-
Target Species of Antibody: Human
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Konzentration
- Lot specific
-
Buffer
- PBS, pH 7.2.
-
Handhabung
- Aliquot to avoid repeated freezing and thawing.
-
Lagerung
- 4 °C,-20 °C
-
Informationen zur Lagerung
- May be stored at 4°C for short-term only. Aliquot to avoid freeze-thaw cycles. Store at -20°C. Aliquots are stable for at least 1 year.
-
-
- BTLA (B and T Lymphocyte Associated (BTLA))
-
Andere Bezeichnung
- BTLA / CD272
-
Hintergrund
-
Name/Gene ID: BTLA
Synonyms: BTLA, BTLA1, B and T lymphocyte associated, CD272, B and T lymphocyte attenuator, B- and T-lymphocyte attenuator, CD272 antigen -
Gen-ID
- 151888
-
NCBI Accession
- NP_861445
-
Pathways
- Cancer Immune Checkpoints
Target
-